INTRODUCTION AND OBJECTIVES: Many patients with neurogenic bladder (NGB) have concomitant erectile dysfunction (ED)
and undergo inflatable penile prosthesis (IPP) placement. These patients carry underlying risk factors associated with their disease, but are also predisposed to poor bladder emptying, urinary incontinence and need for prolonged catheterization after surgery. We compared patients with NGB undergoing IPP to a non-neurogenic control group. METHODS: From 2007 -2018 patients with documented neurogenic bladder and known concomitant neurologic diagnosis (spinal cord injury, Parkinson's disease, multiple sclerosis, diabetes, stroke/ brain injury) underwent IPP placement. This group was compared to 162 non-neurogenic control patients undergoing IPP surgery during the same time period with respect to clinical and demographic characteristics as well as surgical outcomes. Chi-square test was used for categorical variables and Wilcoxon rank sum for continuous variables. Poisson regression was used to evaluate relative risk of complications between the two groups, adjusted for confounding factors.
RESULTS: Patients with NGB were significantly younger, had more prior IPP surgeries, were more likely to require urine control management, and had more IPP related complications (infection, erosion, mechanical failure) ((52.5% vs 8%) p<0.0001). There was no significant difference in the year of surgery, BMI, ethnicity, individual or total number of comorbidities. After adjusting for confounding factors, including age and number of IPP's, relative risk of complication from IPP was significantly higher with NGB patients vs non neurogenic controls ((RR[2.5)(p<0.0001)) CONCLUSIONS: NGB is an independent risk factor for complications associated with IPP placement. Patients should be counseled accordingly and all efforts should be made to optimize bladder function prior to surgery. METHODS: IPP-naïve men over 65 years were prospectively recruited from our outpatient urology clinic. Demographic and selected medical history were recorded. Study participants were asked to squeeze a dynamometer between their thumb and index finger while seated with their arm resting at 90 degrees to measure their key pinch strength. The strongest of three attempts was recorded. Participants were then asked to operate three separate IPP devices (Coloplast Titan, Coloplast Titan Touch, and AMS 700) installed within identical penis models. The number of pumps required to achieve erection with each device was recorded. Patients were asked to rate the difficulty of pumping each device from 1 to 5. Participants were then asked to rank, from best to worst, which device they preferred based on ease of inflation. Multivariate linear regression at the 95% confidence interval was utilized to identify factors associated with difficulty of pumping rated 1 to 5. The order in which the models were presented to participants was randomized to eliminate patient fatigue and bias. RESULTS: A total of 100 men have completed the study. Median age and mean key pinch strength were 70.0 (range 65 to 87) years and 19.5 (SD AE4.2) lbs (comparable to published data among men older than 65 years). The Coloplast Titan pump was ranked the most favored pump based on ease of inflation (58%). AMS 700 was favored by 29% and Coloplast Titan Touch model was favored by 13% of the men. Interestingly, the median age (70.0, 69.0, and 73.0) and mean key pinch strength (19.6, 19.7, and 19 .1 pounds) were similar among men that favored Coloplast Titan as compared to the AMS and Coloplast Titan Touch pump. The median number of pumps required to achieve erection (5.0, 5.0, 6.0) was also similar across the Coloplast Titan, AMS 700, and Coloplast Titan Touch models. Multivariate linear regression of the 1 to 5 difficulty of inflation rating scale showed decreasing grip strength to be associated with increased difficulty of inflation for the Coloplast Titan Touch model (p [ 0.045) . No other factors were significantly associated increased difficulty of inflation. Strengths of our study include strict inclusion criteria, homogeneity of our study population, and randomization of models presented to participants. Limitations include small sample size. Vol. 201, No. 4S, Supplement, Saturday, May 4, 2019 THE JOURNAL OF UROLOGY Ò e369
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